NA
TGTX icon

NewEdge Advisors’s TG Therapeutics TGTX Stock Holding History

NewEdge Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291K Buy
8,760
+53
+0.6% +$1.58K ﹤0.01% 2357
2025
Q4 		$260K Buy
8,707
+20
+0.2% +$653 ﹤0.01% 2412
2025
Q3 		$314K Buy
8,687
+1,094
+14% +$36K ﹤0.01% 2142
2025
Q2 		$273K Hold
7,593
– – ﹤0.01% 2072
2025
Q1 		$299K Buy
7,593
+665
+10% +$22.4K ﹤0.01% 1899
2024
Q4 		$209K Buy
6,928
+6,779
+4,550% +$195K ﹤0.01% 2073
2024
Q3 		$3.48K Buy
+149
New +$3.25K ﹤0.01% 3270
2023
Q3 		– Sell
-9,359
Closed -$232K – 3657
2023
Q2 		$232K Buy
9,359
+8,959
+2,240% +$231K ﹤0.01% 1574
2023
Q1 		$6.02K Buy
+400
New +$6.08K ﹤0.01% 2720

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return